CORCEPT THERAPEUTICS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Corcept Therapeutics Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2024.
  • Corcept Therapeutics Inc Operating Lease, Payments for the quarter ending June 30, 2024 was $741K, a 28.2% increase year-over-year.
  • Corcept Therapeutics Inc Operating Lease, Payments for the twelve months ending June 30, 2024 was $2.59M, a 12.1% increase year-over-year.
  • Corcept Therapeutics Inc annual Operating Lease, Payments for 2023 was $2.39M, a 5.56% increase from 2022.
  • Corcept Therapeutics Inc annual Operating Lease, Payments for 2022 was $2.27M, a 7.65% increase from 2021.
  • Corcept Therapeutics Inc annual Operating Lease, Payments for 2021 was $2.1M, a 14.3% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.59M $741K +$163K +28.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $2.43M $617K +$39K +6.75% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $2.39M $618K +$39K +6.74% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $2.35M $617K +$39K +6.75% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $2.31M $578K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $2.31M $578K +$48K +9.06% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $2.27M $579K +$49K +9.25% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $2.22M $578K +$48K +9.06% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $2.17M $578K +$48K +9.06% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2.12M $530K +$16K +3.11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $2.1M $530K +$17K +3.31% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $2.09M $530K +$16K +3.11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.07M $530K +$108K +25.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.96M $514K +$123K +31.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.84M $513K +$123K +31.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-15
Q3 2020 $1.72M $514K +$123K +31.5% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $1.59M $422K +$31K +7.93% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $1.56M $391K +$12K +3.17% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $1.55M $390K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 $391K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $391K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $379K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.